Notice: Temporary Suspension of New Experiment Creation
We have temporarily disabled the creation of new experiments as we are continuously running out of space. This issue has been impacting both uploads and downloads from FlowRepository. By taking this step, we aim to make downloads of existing data more reliable.
We apologize for the inconvenience and appreciate your understanding as we work on upgrading our hardware and improving the overall solution.
Thank you for your patience.

Download-button_s

Experiment Overview

Repository ID: FR-FCM-Z5PZ Experiment name: KEYNOTE001_UCLA_CYTOF MIFlowCyt score: 29.99%
Primary researcher: Philippe ROCHIGNEUX PI/manager: Philippe ROCHIGNEUX Uploaded by: Philippe ROCHIGNEUX
Experiment dates: 2018-07-01 - 2022-09-04 Dataset uploaded: Sep 2022 Last updated: Sep 2022
Keywords: [immunotherapy] [pembrolizumab] [immune monitoring] [lung cancer] [immune biomarker] [mass cytometry.] Manuscripts:
Organizations: UCLA, Cytometry Core, Los Angeles, (USA)
Purpose: to discover blood baseline immune predictors of pembrolizumab efficacy in advanced NSCLC
Conclusion: see Rochigneux et al., Cancer Research 2022 (in press)
Comments: None
Funding: Fondation de France UNICANCER, Institut Paoli-Calmettes, grant of FRM (Equipe FRM 2018 DEQ20180339209), SIGN’IT grant from Fondation ARC, grant NIH-NCI K08 CA245249-01A1, LUNGevity 2019 Career Development Award,NIH grant (R01 CA208403).
Quality control: in each CYTOF acquisition (barcoded samples), the same healthy donnor was included to minimize batch effect.
Download FCS Files or login and see the dataset in your inbox for further annotation details.